These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 5515370

  • 1. [Effect of physical exercise during drug therapy of chronic cholecystoangiocholitis (clinicophysiological study)].
    Ragimov DM.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1970; 35(6):518-21. PubMed ID: 5515370
    [No Abstract] [Full Text] [Related]

  • 2. [Treatment of chronic cholecystitis and cholecystoangiocholitis with a new Russian preparation oxaphenamide].
    SHAKHNAZAROV AB.
    Klin Med (Mosk); 1961 Jun; 39():100-3. PubMed ID: 13750605
    [No Abstract] [Full Text] [Related]

  • 3. [Use of cholagogic agents in the therapy of patients with dysfunction of the bile-secreting system].
    Nogaller AM, Barkhanova AG, Zakharova GIu.
    Klin Med (Mosk); 1989 Sep; 67(9):129-35. PubMed ID: 2685457
    [No Abstract] [Full Text] [Related]

  • 4. [New therapeutic technic in diseases of the efferent bile ducts].
    Dierel H.
    Wien Med Wochenschr; 1972 Apr 01; 122(14):187-90. PubMed ID: 5014036
    [No Abstract] [Full Text] [Related]

  • 5. [Safe therapy in gallbladder diseases].
    Boecker W.
    Med Welt; 1971 Mar 06; 10():387-91. PubMed ID: 5549138
    [No Abstract] [Full Text] [Related]

  • 6. [The chologenic and choleretic action of sorbitol].
    Grancharov V.
    Vopr Pitan; 1973 Mar 06; 32(2):50-4. PubMed ID: 4782923
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Pharmacological and clinical aspects of the use of a new choleretic, 1-morpholinoacetyl-3-phenyl-4-oxo-1,2,3,4-tetrahydroquinazoline hydrochloride].
    Grossi F, Spada S.
    Clin Ter; 1969 Aug 15; 50(3):203-32. PubMed ID: 5387397
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A rationale for the use of Carlsbad salt-enriched water in treating patients with biliary tract diseases at a sanatorium].
    Ignatova NZ, Garkavi EG.
    Vopr Kurortol Fizioter Lech Fiz Kult; 1989 Aug 15; (6):50-1. PubMed ID: 2534242
    [No Abstract] [Full Text] [Related]

  • 16. [Disorder in mechanisms of bile formation and methods of their correction].
    Iakovenko EP, Grigor'ev PIa, Agafonova NA, Iakovenko AV, Prianishnikova AS.
    Eksp Klin Gastroenterol; 2003 Aug 15; (6):32-9. PubMed ID: 15065526
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Odeston in treatment of chronic diseases of hepatobiliary system].
    Nasonova SV, Lebedeva OI.
    Voen Med Zh; 2001 Feb 15; 322(2):49-53. PubMed ID: 11338822
    [No Abstract] [Full Text] [Related]

  • 19. [Choleretic effect of Bulgarian rose oil].
    Tashev TA, Belousov AS, Gryneharov VP, Zhigalova MF.
    Klin Med (Mosk); 1970 Aug 15; 48(8):57-61. PubMed ID: 5476044
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.